Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew M Thompson

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Journal of Medicinal Chemistry|May 2, 2017
7-Substituted 2-Nitro-5,6-dihydroimidazo[2,1-b][1,3]oxazines: Novel Antitubercular Agents Lead to a New Preclinical Candidate for Visceral LeishmaniasisAndrew M Thompson, Patrick D O'Connor, Andrew J Marshall, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 21, 2023
Π-Π interactions stabilize PeptoMicelle-based formulations of Pretomanid derivatives leading to promising therapy against tuberculosis in zebrafish and mouse modelsNils-Jørgen K Dal, Gabriela Schäfer, Andrew M Thompson, et al.
Chemmedchem|April 1, 2023
Synthesis and Anti-Mycobacterium tuberculosis Activity of Imidazo[2,1-b][1,3]oxazine Derivatives against Multidrug-Resistant StrainsGuilherme F S Fernandes, Karyn F Manieri, Andressa F Bonjorno, et al.
European Journal of Medicinal Chemistry|November 7, 2025
Advancing the antituberculosis activity of nitropicolinic acids and amidesAndrew M Thompson, Chen-Yi Cheung, Matthew B McNeil, et al.
European Journal of Medicinal Chemistry|September 18, 2007
Synthesis and structure-activity relationships of N-6 substituted analogues of 9-hydroxy-4-phenylpyrrolo[3,4-c]carbazole-1,3(2H,6H)-diones as inhibitors of Wee1 and Chk1 checkpoint kinasesJeff B Smaill, Edward N Baker, R John Booth, et al.
European Journal of Medicinal Chemistry|October 2, 2020
Re-evaluating pretomanid analogues for Chagas disease: Hit-to-lead studies reveal both in vitro and in vivo trypanocidal efficacyAndrew M Thompson, Patrick D O'Connor, Andrew J Marshall, et al.
Journal of Medicinal Chemistry|August 5, 2016
Tyrosine Kinase Inhibitors. 20. Optimization of Substituted Quinazoline and Pyrido[3,4-d]pyrimidine Derivatives as Orally Active, Irreversible Inhibitors of the Epidermal Growth Factor Receptor FamilyJeff B Smaill, Andrea J Gonzales, Julie A Spicer, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Journal of Medicinal Chemistry|May 2, 2017
7-Substituted 2-Nitro-5,6-dihydroimidazo[2,1-b][1,3]oxazines: Novel Antitubercular Agents Lead to a New Preclinical Candidate for Visceral LeishmaniasisAndrew M Thompson, Patrick D O'Connor, Andrew J Marshall, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 21, 2023
Π-Π interactions stabilize PeptoMicelle-based formulations of Pretomanid derivatives leading to promising therapy against tuberculosis in zebrafish and mouse modelsNils-Jørgen K Dal, Gabriela Schäfer, Andrew M Thompson, et al.
Chemmedchem|April 1, 2023
Synthesis and Anti-Mycobacterium tuberculosis Activity of Imidazo[2,1-b][1,3]oxazine Derivatives against Multidrug-Resistant StrainsGuilherme F S Fernandes, Karyn F Manieri, Andressa F Bonjorno, et al.
European Journal of Medicinal Chemistry|November 7, 2025
Advancing the antituberculosis activity of nitropicolinic acids and amidesAndrew M Thompson, Chen-Yi Cheung, Matthew B McNeil, et al.
European Journal of Medicinal Chemistry|September 18, 2007
Synthesis and structure-activity relationships of N-6 substituted analogues of 9-hydroxy-4-phenylpyrrolo[3,4-c]carbazole-1,3(2H,6H)-diones as inhibitors of Wee1 and Chk1 checkpoint kinasesJeff B Smaill, Edward N Baker, R John Booth, et al.
European Journal of Medicinal Chemistry|October 2, 2020
Re-evaluating pretomanid analogues for Chagas disease: Hit-to-lead studies reveal both in vitro and in vivo trypanocidal efficacyAndrew M Thompson, Patrick D O'Connor, Andrew J Marshall, et al.
Journal of Medicinal Chemistry|August 5, 2016
Tyrosine Kinase Inhibitors. 20. Optimization of Substituted Quinazoline and Pyrido[3,4-d]pyrimidine Derivatives as Orally Active, Irreversible Inhibitors of the Epidermal Growth Factor Receptor FamilyJeff B Smaill, Andrea J Gonzales, Julie A Spicer, et al.
Pageof 4